Safety and efficacy of autologous, intracoronary stem cell injections in total coronary artery occlusions

Trial Profile

Safety and efficacy of autologous, intracoronary stem cell injections in total coronary artery occlusions

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs ACY 001 (Primary)
  • Indications Coronary artery disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SEACOAST
  • Most Recent Events

    • 09 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top